Randomized evaluation of the safety and efficacy of enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide

✍ Scribed by S.G. Goodman; D. Fitchett; P.W. Armstrong; M. Tan; A. Langer

• Book ID: 114347575
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 41 KB
• Volume: 12
• Category: Article
• ISSN: 1062-1458
• DOI: 10.1016/s1062-1458(03)00186-7